Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model

Vaccine

Volumn 30, Issue 43, 2012, Pages 6198-6209

  Gupta, Ankan ^a   Ahmad, F J ^b   Ahmad, Faiz ^a   Gupta, U D ^c   Natarajan, M ^c   Katoch, V M ^c   Bhaskar, Sangeeta ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b HAMDARD UNIVERSITY   (India)

^c NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

Aerosol delivery; Lung immune response; MIP; Tuberculosis vaccine

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOBACTERIUM INDICUS PRANII VACCINE; MYCOBACTERIUM VACCINE; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUSPENSION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL GUINEA PIG; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; LUNG GRANULOMA; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM INDICUS PRANII; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOSOME; PRIORITY JOURNAL; PROTECTION; TH1 CELL;

ANIMALS; APOPTOSIS; BACTERIAL LOAD; CELL LINE; CYTOKINES; FEMALE; GRANULOMA; GUINEA PIGS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM; NEUTROPHILS; TH1 CELLS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 84865748816     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.061     Document Type: Article

References (45)

1. Andersen P. Tuberculosis vaccines - an update. Nat Rev Microbiol 2007, 5(July (7)):484-487.
2. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346(November (8986)):1339-1345.
3. Sterne J.A., Rodrigues L.C., Guedes I.N. Does the efficacy of BCG decline with time since vaccination?. Int J Tuberc Lung Dis 1998, 2(March (3)):200-207.
4. Fine P.E. BCG: the challenge continues. Scand J Infect Dis 2001, 33(4):243-245.
5. Grode L., Seiler P., Baumann S., Hess J., Brinkmann V., Nasser Eddine A., et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 2005, 115(September (9)):2472-2479.
6. Hoft D.F., Blazevic A., Abate G., Hanekom W.A., Kaplan G., Soler J.H., et al. A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J Infect Dis 2008, 198(November (10)):1491-1501.
7. Jain R., Dey B., Dhar N., Rao V., Singh R., Gupta U., et al. Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One 2008, 3(12):e3869.
8. Dey B., Jain R., Khera A., Gupta U.D., Katoch V.M., Ramanathan V.D., et al. Latency antigen alpha-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines. PLoS One 2011, 6(4):e18773.
9. Dey B., Jain R., Khera A., Rao V., Dhar N., Gupta U.D., et al. Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs. Vaccine 2009, 28(December (1)):63-70.
10. Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Jensen C.G., Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 2006, 177(November (9)):6353-6360.
11. Weinrich O.A., van Pinxteren L.A., Meng O.L., Birk R.P., Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001, 69(May (5)):2773-2778.
12. Olsen A.W., Hansen P.R., Holm A., Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000, 30(June (6)):1724-1732.
13. Reed S.G., Coler R.N., Dalemans W., Tan E.V., DeLa Cruz E.C., Basaraba R.J., et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 2009, 106(February (7)):2301-2306.
14. Dietrich J., Aagaard C., Leah R., Olsen A.W., Stryhn A., doherty T.M., et al. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005, 174(May (10)):6332-6339.
15. Stanford J.L., Rook G.A.W., Bahr G.M., Dowlati Y., Ganapati R., Ghazi Saidi K., et al. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis. Vaccine 1990, 8(December (6)):525-530.
16. Skinner M.A., Yuan S., Prestidge R., Chuk D., Watson J.D., Tan P.L. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect Immun 1997, 65(November (11)):4525-4530.
17. Waddell R.D., Chintu C., Lein A.D., Zumla A., Karagas M.R., Baboo K.S., et al. Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. Clin Infect Dis 2000, 30(June (Suppl. 3)):S309-S315.
18. Brodin P., Majlessi L., Brosch R., Smith D., Bancroft G., Clark S., et al. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. J Infect Dis 2004, 190(July (1)):115-122.
19. Manabe Y.C., Scott C.P., Bishai W.R. Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG. Infect Immun 2002, 70(March (3)):1566-1570.
20. Singh I.G., Mukherjee R., Talwar G.P. Resistance to intravenous inoculation of Mycobacterium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobacterium w. Vaccine 1991, 9(January (1)):10-14.
21. Gupta A., Geetha N., Mani J., Upadhyay P., Katoch V.M., Natrajan M., et al. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route. Infect Immun 2009, 77(January (1)):223-231.
22. Giri P.K., Verma I., Khuller G.K. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice. J Infect 2006, 53(November (5)):350-356.
23. Jeyanathan M., Mu J., Kugathasan K., Zhang X., Damjanovic D., Small C., et al. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung. J Immunol 2008, 181(October (8)):5618-5626.
24. Jeyanathan M., Heriazon A., Xing Z. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol 2010, 31(July (7)):247-252.
25. Jeyanathan M., Mu J., McCormick S., Damjanovic D., Small C.L., Shaler C.R., et al. Murine airway luminal antituberculosis memory CD8T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment. Am J Respir Crit Care Med 2010, 181(April (8)):862-872.
26. Ordway D., Palanisamy G., Henao-Tamayo M., Smith E.E., Shanley C., Orme I.M., et al. The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J Immunol 2007, 179(August (4)):2532-2541.
27. Ordway D., Henao-Tamayo M., Shanley C., Smith E.E., Palanisamy G., Wang B., et al. Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis. Clin Vaccine Immunol 2008, 15(August (8)):1248-1258.
28. Ordway D.J., Shanley C.A., Caraway M.L., Orme E.A., Bucy D.S., Dove L.H., et al. Evaluation of standard chemotherapy in the guinea pig model of tuberculosis. Antimicrob Agents Chemother 2010, 54(May (5)):1820-1833.
29. Kraal G., Twisk A., Tan B., Scheper R. A surface molecule on guinea pig lymphocytes involved in adhesion and homing. Eur J Immunol 1986, 16(December (12)):1515-1519.
30. Schafer H., Scheper R.J., Healey D.G., Schenkel J., Burger R. T cell proliferation induced by monoclonal antibodies to a phosphatidylinositol-linked differentiation antigen of guinea pig lymphocytes. Eur J Immunol 1991, 21(March (3)):701-705.
31. Yamada H., Udagawa T., Mizuno S., Hiramatsu K., Sugawara I. Newly designed primer sets available for evaluating various cytokines and iNOS mRNA expression in guinea pig lung tissues by RT-PCR. Exp Anim 2005, 54(April (2)):163-172.
32. Ly L.H., Russell M.I., McMurray D.N. Cytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis. Am J Respir Cell Mol Biol 2008, 38(April (4)):455-462.
33. Cho H., Lasco T.M., Allen S.S., Yoshimura T., McMurray D.N. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun 2005, 73(March (3)):1367-1376.
34. Skwor T.A., Sedberry A.S., Mackie J.T., Russell K., Berghman L.R., McMurray D.N. BCG vaccination of guinea pigs modulates Mycobacterium tuberculosis-induced CCL5 (RANTES) production in vitro and in vivo. Tuberculosis (Edinb) 2006, 86(November (6)):419-429.
35. Kelly D.M., ten Bokum A.M., O'Leary S.M., O'Sullivan M.P., Keane J. Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection. Infect Immun 2008, 76(January (1)):351-360.
36. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci USA 2003, 100(April (9)):5437-5442.
37. Kyei G.B., Vergne I., Chua J., Roberts E., Harris J., Junutula I., et al. Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. EMBO J 2006, 25(November (22)):5250-5259.
38. Lowrie D.B., Aber V.R., Jackett P.S. Phagosome-lysosome fusion and cyclic adenosine 3':5'-monophosphate in macrophages infected with Mycobacterium microti, Mycobacterium bovis BCG or Mycobacterium lepraemurium. J Gen Microbiol 1979, 110(February (2)):431-441.
39. Sun J., Deghmane A.E., Soualhine H., Hong T., Bucci C., Slodkin A., et al. Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation. J Leukoc Biol 2007, 82(December (6)):1437-1445.
40. Chen L., Wang J., Zganiacz A., Xing Z. Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis. Infect Immun 2004, 72(January (1)):238-246.
41. Falero-Diaz G., Challacombe S., Banerjee D., Douce G., Boyd A., Ivanyi J. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine 2000, 18(August (28)):3223-3229.
42. Kamath A.T., Fruth U., Brennan M.J., Dobbelaer R., Hubrechts P., Ho M.M., et al. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. Vaccine 2005, 23(May (29)):3753-3761.
43. Kapina M.A., Shepelkova G.S., Mischenko V.V., Sayles P., Bogacheva P., Winslow G., et al. CD27low CD4T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection. J Immunol 2007, 178(January (2)):976-985.
44. Balcewicz-Sablinska M.K., Keane J., Kornfeld H., Remold H.G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 1998, 161(September (5)):2636-2641.
45. Klingler K., Tchou-Wong K.M., Brandli O., Aston C., Kim R., Chi C., et al. Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect Immun 1997, 65(December (12)):5272-5278.